title: Omalizumab treatment in brittle asthma.
abstract: Asthma is a heterogeneous disease with variable characteristics such as lung function, symptoms and control, body weight, pattern of inflammation, and response to treatment. Brittle asthma is one of clinical phenotypes of asthma with unclear pathogenic mechanisms and appropriate treatment. Analysis of 2 described cases suggests that omalizumab could be useful in the treatment of brittle allergic asthma.
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Roman
authors.initials: R
authors.lastname: Skiepko
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Ziemowit
authors.initials: Z
authors.lastname: Zietkowski
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Urszula
authors.initials: U
authors.lastname: Skiepko
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Wojciech
authors.initials: W
authors.lastname: Budny
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Mateusz
authors.initials: M
authors.lastname: Lukaszyk
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. Head of Department: Prof. Anna Bodzenta-Lukaszyk MD, PhD.
authors.forename: Anna
authors.initials: A
authors.lastname: Bodzenta-Lukaszyk
keywords: brittle asthma; omalizumab